USPTO 2015–2025 USPTO PatentsView US Corporation

Medline Industries, LP

USPTO PatentsView assignee record — 753 granted patents across 80 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

753
Total patents granted
80
CPC technology areas
10.3
Avg claims per patent
+18%
5-year filing velocity

Portfolio overview

Medline Industries, LP has been granted 753 US utility patents between 2015 and 2025, placing Medline Industries, LP at rank #592 across all assignees tracked by PlainPatent. This portfolio spans 80 distinct Cooperative Patent Classification (CPC) subclasses, averaging 10.3 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Medline Industries, LP is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 58.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 408 grants, compared with 345 in the 2015–2019 window — a +18% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Medline Industries, LP's 10.3 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a multi-domain presence across 80 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Medline Industries, LP against peers pursuing similar technology classes.

How does Medline compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Medline holds 753 patents — placing it at rank #592 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2025

20406080100120 20152016201720182019202020212022202320242025 41
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Medline Industries, LP patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 42 5.6%
2016 60 8.0%
2017 88 11.7%
2018 71 9.4%
2019 84 11.2%
2020 105 13.9%
2021 77 10.2%
2022 56 7.4%
2023 77 10.2%
2024 52 6.9%
2025 41 5.4%

Which technologies does Medline Industries, LP patent most?

Top 15 of 80 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Simple
Velocity Growing

Where it ranks

Overall rank by patents

#592

Across all tracked assignees

Innovation Score

58.7 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Medline Industries, LP hold?
Medline Industries, LP holds 753 US granted patents filed between 2015 and 2025, spanning 80 technology areas.
What is Medline Industries, LP's Innovation Score?
Medline Industries, LP has an Innovation Score of 58.7 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Medline Industries, LP focus on?
Medline Industries, LP's top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 135 patents. The company has filed patents in 80 CPC subclasses total.
Is Medline Industries, LP's patent filing rate increasing or decreasing?
Medline Industries, LP's recent filing velocity is +18% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for Medline Industries, LP's patents?
Medline Industries, LP's patents average 10.3 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the Medline Industries, LP patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope